Literature DB >> 6402218

Neurological effects of recombinant human interferon.

L Honigsberger, J W Fielding, T J Priestman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6402218      PMCID： PMC1547057          DOI： 10.1136/bmj.286.6366.719-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  Preliminary observations on the pharmacokinetics of human lymphoblastoid interferon given by intramuscular injection.

Authors:  T J Priestman; M Johnston; P D Whiteman
Journal:  Clin Oncol       Date:  1982

2.  Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease.

Authors:  T J Priestman
Journal:  Lancet       Date:  1980-07-19       Impact factor: 79.321
  2 in total
  3 in total

1.  A Brief Historical Perspective on the Pathological Consequences of Excessive Type I Interferon Exposure In vivo.

Authors:  Yanick J Crow; Pierre Lebon; Jean-Laurent Casanova; Ion Gresser
Journal:  J Clin Immunol       Date:  2018-09-05       Impact factor: 8.317

2.  Common emergencies in cancer medicine: infectious and treatment-related syndromes, Part II.

Authors:  C R Thomas; K J Stelzer; J G Douglas; W J Koh; L V Wood; R Panicker
Journal:  J Natl Med Assoc       Date:  1994-11       Impact factor: 1.798

Review 3.  Preclinical safety testing of species-specific proteins produced with recombinant DNA-techniques. An attempt to transfer current experience into future testing strategies.

Authors:  K Teelmann; C Hohbach; H Lehmann
Journal:  Arch Toxicol       Date:  1986-12       Impact factor: 5.153
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.